Linhai Li

2.0k total citations
83 papers, 1.3k citations indexed

About

Linhai Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Linhai Li has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 15 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Linhai Li's work include SARS-CoV-2 and COVID-19 Research (8 papers), Epigenetics and DNA Methylation (8 papers) and Ferroptosis and cancer prognosis (6 papers). Linhai Li is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Epigenetics and DNA Methylation (8 papers) and Ferroptosis and cancer prognosis (6 papers). Linhai Li collaborates with scholars based in China, United Kingdom and United States. Linhai Li's co-authors include Bin Xiao, Weiyun Zhang, Yiming Ouyang, Qingjun Ma, Zhaohui Sun, Ping Li, Jianfeng Hang, Yuejin Li, Yuling Shi and Zhenzhan Kuang and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Linhai Li

78 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linhai Li China 23 592 285 229 177 153 83 1.3k
Tuoen Liu United States 12 852 1.4× 138 0.5× 141 0.6× 152 0.9× 101 0.7× 23 1.3k
Xiaorong Liu China 21 707 1.2× 257 0.9× 155 0.7× 74 0.4× 144 0.9× 90 1.4k
María Maximina Bertha Moreno‐Altamirano Mexico 16 469 0.8× 262 0.9× 215 0.9× 499 2.8× 115 0.8× 30 1.3k
Gudrun Totzke Germany 19 565 1.0× 217 0.8× 118 0.5× 232 1.3× 236 1.5× 29 1.2k
Franck B. Riquet France 15 519 0.9× 84 0.3× 163 0.7× 122 0.7× 104 0.7× 26 1.0k
Yuanyuan Wang China 21 982 1.7× 329 1.2× 116 0.5× 322 1.8× 231 1.5× 60 1.8k
Xin Yao China 17 1.2k 2.1× 292 1.0× 78 0.3× 132 0.7× 81 0.5× 41 1.7k
Kamran Kadkhoda Canada 16 582 1.0× 129 0.5× 162 0.7× 179 1.0× 146 1.0× 33 1.2k
Jui Pandhare United States 23 771 1.3× 369 1.3× 194 0.8× 170 1.0× 155 1.0× 47 1.4k
Jayanta K. Pal India 25 1.4k 2.3× 209 0.7× 89 0.4× 254 1.4× 206 1.3× 95 2.0k

Countries citing papers authored by Linhai Li

Since Specialization
Citations

This map shows the geographic impact of Linhai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linhai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linhai Li more than expected).

Fields of papers citing papers by Linhai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linhai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linhai Li. The network helps show where Linhai Li may publish in the future.

Co-authorship network of co-authors of Linhai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Linhai Li. A scholar is included among the top collaborators of Linhai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linhai Li. Linhai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Ji, Sicheng Liu, Libo Yang, et al.. (2025). miR-28–3p suppresses gastric cancer growth and EMT-driven metastasis by targeting the ARF6/Hedgehog axis. Molecular and Cellular Probes. 79. 102010–102010.
2.
Liu, Yunduo, Yanxia Zhang, Qin Xiang, et al.. (2025). Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation. European Journal of Pharmacology. 991. 177343–177343. 1 indexed citations
3.
Teng, Xu, Tao Liu, Guifang Zhao, et al.. (2024). A novel exosome-based multifunctional nanocomposite platform driven by photothermal-controlled release system for repair of skin injury. Journal of Controlled Release. 371. 258–272. 23 indexed citations
4.
Liu, Yunduo, Mei Zhang, Guanjie Li, et al.. (2024). Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple‐Negative Breast Cancer: A Comprehensive Analysis. PPAR Research. 2024(1). 4164906–4164906. 1 indexed citations
5.
Xiao, Bin, et al.. (2023). Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development. European Journal of Pharmacology. 964. 176304–176304. 11 indexed citations
6.
Qu, Jing, et al.. (2023). The diagnostic value of serum lncRNA CATG00000112921.1 as a marker of multiple myeloma. Current Problems in Cancer. 48. 101057–101057.
7.
Xiao, Bin, Xiaoyan Huang, Jinchao Li, et al.. (2023). Rapid Detection of blaKPC in Carbapenem-Resistant Enterobacterales Based on CRISPR/Cas13a. Current Microbiology. 80(11). 352–352. 9 indexed citations
8.
Wu, Yongjian, Qiaohua Wang, Miao Li, et al.. (2023). SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis. Journal of Clinical Investigation. 133(6). 33 indexed citations
9.
Lei, Ting, Wenwu Zhang, Xiaoyu Song, et al.. (2022). ZNF276 promotes the malignant phenotype of breast carcinoma by activating the CYP1B1-mediated Wnt/β-catenin pathway. Cell Death and Disease. 13(9). 781–781. 16 indexed citations
10.
Liu, Yanmei, Meifang Zhou, Peng Zhou, et al.. (2021). Establishment and Clinical Application of a Method for Detecting T Lymphocyte Subsets by Cellular Immunochip Technology. SHILAP Revista de lepidopterología. 3 indexed citations
11.
Liu, Bochao, Xi Tang, Xin Zheng, et al.. (2021). Role of core protein mutations in the development of occult HBV infection. Journal of Hepatology. 74(6). 1303–1314. 7 indexed citations
12.
Zhang, Linjing, et al.. (2021). Chemical constituents and their anti-inflammatory activity from twigs of Ormosia hosiei Hemsl.& E.H.Wilson. Tianran chanwu yanjiu yu kaifa. 33(4). 585. 2 indexed citations
13.
Xiao, Bin, Jianfeng Hang, Ting Lei, et al.. (2019). Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system. Molecular Biology Reports. 46(2). 2111–2119. 17 indexed citations
14.
He, Rongqiao, et al.. (2019). MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL. BioMed Research International. 2019. 1–9. 18 indexed citations
15.
Wang, Li, Lijie Song, Juan Li, et al.. (2019). Bone sialoprotein‐αvβ3 integrin axis promotes breast cancer metastasis to the bone. Cancer Science. 110(10). 3157–3172. 30 indexed citations
16.
Xiao, Bin, Quan Zhou, Jianfeng Hang, et al.. (2019). Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p. BMC Cancer. 19(1). 891–891. 40 indexed citations
17.
Xiao, Bin, Zhenzhan Kuang, Weiyun Zhang, et al.. (2019). Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial‐mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling. Molecular Carcinogenesis. 58(7). 1314–1323. 23 indexed citations
18.
Xiao, Bin, Jianfeng Hang, Ling Cao, et al.. (2018). Identification of methylation sites and signature genes with prognostic value for luminal breast cancer. BMC Cancer. 18(1). 405–405. 43 indexed citations
19.
Jiang, Hang, et al.. (2017). CXCR5 + CD8 + T Cells Indirectly Offer B Cell Help and Are Inversely Correlated with Viral Load in Chronic Hepatitis B Infection. DNA and Cell Biology. 36(4). 321–327. 34 indexed citations
20.
Li, Linhai, et al.. (2012). Distribution of Aquilaria sinensis (Thymelaeaceae).. Medicinal plant. 3(10). 8–13. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuoen Liu Breakdown of academic impact, for papers by Xiaorong Liu Breakdown of academic impact, for papers by María Maximina Bertha Moreno‐Altamirano Breakdown of academic impact, for papers by Gudrun Totzke Breakdown of academic impact, for papers by Franck B. Riquet Breakdown of academic impact, for papers by Yuanyuan Wang Breakdown of academic impact, for papers by Xin Yao Breakdown of academic impact, for papers by Kamran Kadkhoda Breakdown of academic impact, for papers by Jui Pandhare Breakdown of academic impact, for papers by Jayanta K. Pal
Rankless by CCL
2026